Myelodysplastic Syndrome (MDS)

The Myelodysplastic Syndrome (MDS) program at Mount Sinai is lead by Lewis Silverman, MD. Dr. Silverman has served as the Principal Investigator for several national clinical trials exploring treatments for patients with MDS (a pre-leukemic condition), and has brought forward for FDA approval the first drug that is effective in treating MDS.